英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Velufenacin |
化合物VELUFENACIN |
1648737-78-3 |
詳細(xì)
|
PCNA-I1 |
PCNA-I1 |
444930-42-1 |
詳細(xì)
|
EG1 |
2-(4-(2-甲氧基苯甲酰氨基)苯甲酰氨基)苯甲酸 |
693241-54-2 |
詳細(xì)
|
CID44216842 |
KUC103479N-02 |
1222513-26-9 |
詳細(xì)
|
MLS-573151 |
MLS-573151 |
10179-57-4 |
詳細(xì)
|
AGX51 |
N-[3-(1,3-benzodioxol-5-yl)-3-(2-methoxyphenyl)propyl]-N-benzylpropanamide |
330834-54-3 |
詳細(xì)
|
NG-25 |
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺 |
1315355-93-1 |
詳細(xì)
|
DS18561882 |
DS18561882 |
2227149-22-4 |
詳細(xì)
|
AST487 |
AST 487 |
630124-46-8 |
詳細(xì)
|
Cedirogant |
4-Piperidineacetic acid, 1-[2,4-dichloro-3-[[7-chloro-5-(trifluoromethyl)-1H-indol-1-yl]methyl]benzoyl]- |
2055496-11-0 |
詳細(xì)
|
SR9238 |
1416153-62-2 |
1416153-62-2 |
詳細(xì)
|
BAY-218 |
CPD3504 |
2162982-11-6 |
詳細(xì)
|
Dalpiciclib free base |
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-piperidinyl)-2-pyridinyl]amino]- |
1637781-04-4 |
詳細(xì)
|
BAY-179 |
化合物BAY-179 |
|
詳細(xì)
|
Bromosporine |
C17H20N6O4S |
1619994-69-2 |
詳細(xì)
|
Grp94inhibitor-1 |
GRP94 |
2234897-35-7 |
詳細(xì)
|
YKL 06-061 |
YKL 06-061 |
2172617-15-9 |
詳細(xì)
|
CC-90010 |
CC-90010 |
1706738-98-8 |
詳細(xì)
|
NEO2734 (EP31670) |
化合物NEO2734 |
2081072-29-7 |
詳細(xì)
|
PLX51107 |
化合物PLX51107 |
1627929-55-8 |
詳細(xì)
|
UNC-1215 |
UNC1215 |
1415800-43-9 |
詳細(xì)
|
Bevenopran |
676500-67-7 |
676500-67-7 |
詳細(xì)
|
Toceranib |
Toceranib |
356068-94-5 |
詳細(xì)
|
4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl |
泊馬度胺 4'-PEG1-胺 |
2154342-56-8 |
詳細(xì)
|
FIPI |
FIPI |
939055-18-2 |
詳細(xì)
|
Laquinimod |
拉喹莫德 |
248281-84-7 |
詳細(xì)
|
SB 218795 |
化合物 T23316 |
174635-53-1 |
詳細(xì)
|
GSK854 |
3-((6-((5-chloropyridin-2-yl)amino)pyrimidin-4-yl)amino)-4-(ethylsulfonyl)-N-methylbenzenesulfonamide |
1316059-00-3 |
詳細(xì)
|
Mibampator(LY451395) |
MIBAMPATOR |
375345-95-2 |
詳細(xì)
|
(S)-6-(4-chlorophenyl)-N-(1-hydroxypropan-2-yl)-2-(1-methyl-1H-pyrazol-4-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide |
AHR antagonist 3 |
2242464-44-2 |
詳細(xì)
|
3-Pyridinecarboxylic acid, 5-bromo- |
5-溴煙酸 |
20826-04-4 |
詳細(xì)
|
LMI070 |
化合物L(fēng)MI 070 |
1562338-42-4 |
詳細(xì)
|
tasquinimod |
他喹莫德 |
254964-60-8 |
詳細(xì)
|
2-[2-(quinolin-3-yl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one |
2-[2-(3-quinolyl)-4-pyridyl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one |
724711-21-1 |
詳細(xì)
|
CASIN |
CASIN |
425399-05-9 |
詳細(xì)
|
RIPA-56 |
RIPA-56 |
1956370-21-0 |
詳細(xì)
|
MCP110 |
化合物 T24437 |
521310-51-0 |
詳細(xì)
|
HS-1371 |
HS1371 |
2158197-70-5 |
詳細(xì)
|
PF-5274857 |
PF-5274857 |
1373615-35-0 |
詳細(xì)
|
Ceapin-A7 |
N-(1-(2,4-雙(三氟甲基)芐基)-1H-吡唑-4-基)-5-(呋喃-2-基)異惡唑-3-甲酰胺 |
2323027-38-7 |
詳細(xì)
|
K-756 |
130017-40-2 |
130017-40-2 |
詳細(xì)
|
SBI-797812 |
SBI-797812 |
2237268-08-3 |
詳細(xì)
|
NK-252 |
1414963-82-8 |
1414963-82-8 |
詳細(xì)
|
4E2RCat |
432499-63-3 |
432499-63-3 |
詳細(xì)
|
N-ETHYL-2-[(6-METHOXYPYRIDIN-3-YL)-(2-METHYLPHENYL)SULFONYLAMINO]-N-(PYRIDIN-3-YLMETHYL)ACETAMIDE |
N-ETHYL-2-[(6-METHOXYPYRIDIN-3-YL)-(2-METHYLPHENYL)SULFONYLAMINO]-N-(PYRIDIN-3-YLMETHYL)ACETAMIDE |
680590-49-2 |
詳細(xì)
|
GSK583 |
6-(叔丁基磺?;?-N-(5-氟-1H-吲唑-3-基)喹啉-4-胺 |
1346547-00-9 |
詳細(xì)
|
APD668 |
APD668 |
832714-46-2 |
詳細(xì)
|
Palosuran |
ACT 058362; PALOSURAN, |
540769-28-6 |
詳細(xì)
|
SK2033 |
GSK 2033 |
1221277-90-2 |
詳細(xì)
|
PFI-1 |
PFI-1 (PF-6405761) |
1403764-72-6 |
詳細(xì)
|
BRD4-IN-1 ( FL411 ) |
2-(4-羥基-3,5-二甲基苯基)-7-甲基-5,6,7,8-四氫吡啶并[4',3':4,5]噻吩并[2,3-D]嘧啶-4(1H)-酮 |
2118944-88-8 |
詳細(xì)
|
SR18662 |
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide |
2505001-62-5 |
詳細(xì)
|
SR15006 |
SR 15006 |
2505001-54-5 |
詳細(xì)
|
BMS-833923 |
BMS-833923 |
1059734-66-5 |
詳細(xì)
|
A-443654 |
(ALPHAS)-ALPHA-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧基]甲基]-(S)-1H-吲哚-3-乙胺 |
552325-16-3 |
詳細(xì)
|
DUN61488 |
ONC212 |
1807861-48-8 |
詳細(xì)
|
PHT-427 |
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 |
1191951-57-1 |
詳細(xì)
|
DY 268 |
DY 268 |
1609564-75-1 |
詳細(xì)
|
GNE-9815 |
化合物GNE-9815 |
2729996-45-4 |
詳細(xì)
|
ATC 0175 hydrochloride |
ATC 0175 |
510733-97-8 |
詳細(xì)
|
Ezatiostat |
EZATIOSTAT游離的 |
168682-53-9 |
詳細(xì)
|
LDN-193189 (DM3189) 2HCl |
LDN-193189 2HCL |
1435934-00-1 |
詳細(xì)
|
TAK-901 |
5-[3-(乙基磺酰基)苯基]-3,8-二甲基-N-(1-甲基-4-哌啶基)-9H-吡啶并[2,3-B]吲哚-7-甲酰胺 |
934541-31-8 |
詳細(xì)
|
Perospirone |
哌羅匹隆 |
150915-41-6 |
詳細(xì)
|
CCR6 inhibitor 1 |
2-Pyridinecarboxamide, 4-[4-[[trans-4-[[5-(trifluoromethyl)-2-pyridinyl]amino]cyclohexyl]sulfonyl]phenyl]- |
2437547-04-9 |
詳細(xì)
|
Mebeverine Acid |
美貝維林 鹽酸鹽 |
475203-77-1 |
詳細(xì)
|
SR-2211 |
2-Fluoro-4'-[[4-(4-pyridinylMethyl)-1-piperazinyl]Methyl]-偽,偽-bis(trifluoroMethyl)-[1,1'-biphenyl]-4-Methanol |
1359164-11-6 |
詳細(xì)
|
Teijin compound 1 |
化合物 T19230 |
1313730-14-1 |
詳細(xì)
|
PIK-93 |
N-[5-[4-氯-3-[[(2-羥基乙基)氨基]磺?;鵠苯基]-4-甲基-2-噻唑基]乙酰胺 |
593960-11-3 |
詳細(xì)
|
SB 657510 |
2-溴-N-[4-氯-3-[[(3R)-1-甲基-3-吡咯烷基]氧基]苯基]-4,5-二甲氧基-苯磺酰胺 |
474960-44-6 |
詳細(xì)
|
Sivelestat (ONO5046, LY544349, EI546) |
西維來司他 |
127373-66-4 |
詳細(xì)
|
UNC0379 |
UNC0379 |
1620401-82-2 |
詳細(xì)
|
SR10067 |
3-[[4-(1,1-Dimethylethoxy)phenoxy]methyl]-3,4-dihydro-2(1H)-isoquinolinyl]-1-naphthalenylmethanone |
1380548-02-6 |
詳細(xì)
|
FGTI-2734 |
FGTI-2734 |
1247018-19-4 |
詳細(xì)
|
Ulixacaltamide (Z944) |
N-((1-(2-(叔丁基氨基)-2-氧代乙基)哌啶-4-基)甲基)-3-氯-5-氟苯甲酰胺 |
1199236-64-0 |
詳細(xì)
|
SYP-5 |
1384268-04-5 |
1384268-04-5 |
詳細(xì)
|
WS6 |
WS6 |
1421227-53-3 |
詳細(xì)
|
ZINC00881524 |
557782-81-7 |
557782-81-7 |
詳細(xì)
|
Sulfatinib |
5-羥基-2-甲基吲哚 |
1308672-74-3 |
詳細(xì)
|
LP-935509 |
化合物L(fēng)P-935509 |
1454555-29-3 |
詳細(xì)
|
Dacinostat |
達(dá)諾司他 |
404951-53-7 |
詳細(xì)
|
STF-62247 |
N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 |
315702-99-9 |
詳細(xì)
|
Lofepramine |
洛非帕明 |
23047-25-8 |
詳細(xì)
|
JC124 |
Benzamide, 5-chloro-2-methoxy-N-[2-[4-[(methylamino)sulfonyl]phenyl]ethyl]- |
1638611-48-9 |
詳細(xì)
|
Dovramilast |
化合物 DOVRAMILAST |
340019-69-4 |
詳細(xì)
|
NVP-BHG712 |
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
940310-85-0 |
詳細(xì)
|
NVP-BVU 972 |
6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]噠嗪-3-基]甲基]喹啉 |
1185763-69-2 |
詳細(xì)
|
AZ960 |
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈 |
905586-69-8 |
詳細(xì)
|
H3B-120 |
H3B-120 |
2194903-42-7 |
詳細(xì)
|
KHS101 hydrochloride |
鹽酸KHS101 |
1784282-12-7 |
詳細(xì)
|
V-9302 |
V-9302 |
1855871-76-9 |
詳細(xì)
|
Tigulixostat |
化合物 TIGULIXOSTAT |
1287766-55-5 |
詳細(xì)
|
Benzamide, 4-butoxy-N-[[4-(dimethylamino)tetrahydro-2H-pyran-4-yl]methyl]-3,5-dimethoxy-, hydrochloride (1:1) |
Opiranserin鹽酸鹽 |
1440796-75-7 |
詳細(xì)
|
VY-3-135 |
化合物VY-3-135 |
|
詳細(xì)
|
CHD1Li 6.11 |
化合物 CHD1LI 6.11 |
2716890-91-2 |
詳細(xì)
|
BAY-1797 |
BAY-1797 |
2055602-83-8 |
詳細(xì)
|
Benzenesulfonamide, 3,4-dimethoxy-N-[4-(3-nitrophenyl)-2-thiazolyl]- |
RO 61-8048 |
199666-03-0 |
詳細(xì)
|
WQ 1 |
化合物Σ1 RECEPTOR ANTAGONIST-1 |
1204401-49-9 |
詳細(xì)
|
BCI-121 |
BCI-121 |
432529-82-3 |
詳細(xì)
|
IWP-L6 |
IWP-L6 |
1427782-89-5 |
詳細(xì)
|